Zeynep B Erton, Rebecca K Leaf, Danieli de Andrade, Ann E Clarke, Maria G Tektonidou, Vittorio Pengo, Savino Sciascia, Amaia Ugarte, H Michael Belmont, Maria Gerosa, Paul R Fortin, Chary Lopez-Pedrera, Tatsuya Atsumi, Zhouli Zhang, Hannah Cohen, Guilherme Ramires de Jesús, David W Branch, Denis Wahl, Laura Andreoli, Esther Rodriguez-Almaraz, Michelle Petri, Giuseppe Barilaro, Yu Zuo, Bahar Artim-Esen, Rohan Willis, Rosana Quintana, Margarete Bg Vendramini, Megan W Barber, Maria L Bertolaccini, Robert Roubey, Doruk Erkan
BACKGROUND/PURPOSE: APS ACTION Registry was created to study the outcomes of patients with persistently positive antiphospholipid antibodies (aPL) with or without other systemic autoimmune disease (SAIDx). Given that immunosuppression (IS) is used for certain aPL manifestations, for example, thrombocytopenia (TP), our primary objective was to describe the indications for IS in aPL-positive patients without other SAIDx. Secondly, we report the type of IS used in patients with selected microvascular or non-thrombotic aPL manifestations...
December 2022: Lupus